The University of Birmingham has developed a cell-penetrating peptide it claims could be used to make eye drop versions of age-related macular degeneration drugs currently delivered by injection.
Ohr Pharmaceutical Inc. has halted activities at the laboratory in San Diego, California where research on its sustained release delivery technology was carried out.
Researchers have developed a Trojan-horse-style delivery system that transports steroids to the retina for the treatment of age-related macular degeneration and retinitis pigmentosa.
Despite Genentech's recent decision to push out the cut-off date to
ban the sale of cancer drug Avastin (bevacizumab) to compounding
pharmacies in the US to restrict off-label use, ophthalmologists
still find the firm's...
A study has suggested the hypoxia inducible gene RTP801 may serve
an important mechanistic role in the development of experimental
chordial neovascularisation (CNV), the principal cause of
Age-related Macular Degeneration (AMD).
